Mangin 2015.

Methods	Randomised controlled trial
Participants	Primary care‐treated patients currently taking fluoxetine for maintenance to prevent recurrence of depression
Interventions	Intervention 1: discontinuation by taper to placebo Intervention 2: continuation of maintenance SSRI Trial duration: 18 months
Outcomes	‐ occurrence of moderately severe depression over 18 months ‐ mood ‐ quality of life ‐ overall psychological distress/symptoms ‐ social and occupational functioning
Notes	Last participants enrolled 15/02/2012 Results were presented at North American Primary Care Research Group (NAPCRG) 43rd Annual Meeting; Oct 27, 2015; Cancun, Mexico Contact information: mangind@mcmaster.ca (we requested data but have not received response)